Annual Drug Patent Expirations for ERAXIS
Eraxis is a drug marketed by Vicuron and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has sixty-four patent family members in twenty-nine countries.
The generic ingredient in ERAXIS is anidulafungin. One supplier is listed for this compound. Additional details are available on the anidulafungin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com